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Implementation activities for a chemically-defined media platform to
minimize media variability impact to cell culture performance and product
quality
Martin Gawlitzek, Brian Wong, Robert Shawley, Masaru Shiratori
Chemically-defined media have been developed for CHO cell culture platform
processes. During implementation of the media at multiple scales and sites
globally, additional activities were required to seamlessly balance practical
considerations with desired process and product quality performance. Three
main focus areas were further investigated and optimized to enable the platform
implementation: 1) media preparation, filtration, and post-filtration stability; 2)
media and supplement viral barrier compatibility; and 3) and raw material
variability considerations. Overall, the effort provided an outlined approach for
media implementation in the global network including scale and site-specific case
studies where novel options were required.
The data generated supported successful implementation of chemically-defined
platform media at different global sites within our network. Manufacturing-scale
media preparations met acceptance criteria and resulted in comparable cell
culture performance and product quality to controls. Practical challenges were
identified and risk mitigation efforts initiated. The challenges were primarily
related to poorly-defined media preparation mixing environments as a result of
variable equipment availability and use. Filtration capacity acceptance criteria
were met in the scale-down model and large-scale filtration events were
successful. HTST-compatibility studies showed that HTST-treated media
performed comparably to control media in cell culture performance and product
quality. Post-filtration media stability investigations led to the identification of key
risk factors including temperature and agitation variation during storage,
nucleation and media destabilization as a result of specific handling practices,
and the impact of specific process-contacting materials. Options for mitigating the
media stability risks and enabling successful implementation were developed and
showed no negative impact for the application. Finally, platform media
modifications were developed to mitigate raw material variation and product
quality challenges. The overall evolution of the media platform to ensure flexibility
and successful implementation will be summarized.

